Trial
NCT04214093
A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
—
Condition
Advanced Solid Tumors
Intervention
AZD0466
Why stopped
Strategic change to clinical development plan
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-02